相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Macrophages are critical to the maintenance of IL-13-dependent lung inflammation and fibrosis
L. A. Borthwick et al.
MUCOSAL IMMUNOLOGY (2016)
Histone deacetylase inhibitors attenuate P-algA1-induced cell proliferation and extracellular matrix synthesis in human renal mesangial cells in vitro
Qin Dai et al.
ACTA PHARMACOLOGICA SINICA (2016)
Valproic acid reduces insulin-resistance, fat deposition and FOXO1-mediated gluconeogenesis in type-2 diabetic rat
Sabbir Khan et al.
BIOCHIMIE (2016)
Improving understanding of chromatin regulatory proteins and potential implications for drug discovery
Haloom Rafehi et al.
EXPERT REVIEW OF PROTEOMICS (2016)
Keloids: The paradigm of skin fibrosis - Pathomechanisms and treatment
Jonathan P. Andrews et al.
MATRIX BIOLOGY (2016)
Skin tissue repair: Matrix microenvironmental influences
Alan Wells et al.
MATRIX BIOLOGY (2016)
Class-Specific Histone/Protein Deacetylase Inhibition Protects Against Renal Ischemia Reperfusion Injury and Fibrosis Formation
M. H. Levine et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Implication of epigenetics in pancreas development and disease
Evans Quilichini et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Epigenetic modifications by histone deacetylases: Biological implications and therapeutic potential in liver fibrosis
Pei-Jie Chen et al.
BIOCHIMIE (2015)
Valproate attenuates the proteinuria, podocyte and renal injury by facilitating autophagy and inactivation of NF-κB/iNOS signaling in diabetic rat
Sabbir Khan et al.
BIOCHIMIE (2015)
PDGF-D signaling in portal myofibroblasts and hepatic stellate cells proves identical to PDGF-B via both PDGF receptor type α and β
Erawan Borkham-Kamphorst et al.
CELLULAR SIGNALLING (2015)
Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat
Sabbir Khan et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2015)
Bone marrow-derived fibrocytes contribute to liver fibrosis
Jun Xu et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Sodium Butyrate Ameliorates l-Arginine-Induced Pancreatitis and Associated Fibrosis in Wistar Rat: Role of Inflammation and Nitrosative Stress
Gayathri Kanika et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2015)
The Dishevelled-binding protein CXXC5 negatively regulates cutaneous wound healing
Soung-Hoon Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Matrix metalloproteinases in liver injury, repair and fibrosis
Sergio Duarte et al.
MATRIX BIOLOGY (2015)
Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis
Katrin Palumbo-Zerr et al.
NATURE MEDICINE (2015)
Role of non-classical renin-angiotensin system axis in renal fibrosis
Lin-Li Lv et al.
FRONTIERS IN PHYSIOLOGY (2015)
Valproate ameliorates thioacetamide-induced fibrosis by hepatic stellate cell inactivation
J. S. Aher et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2015)
Protective Effects of Valproic Acid, a Histone Deacetylase Inhibitor, against Hyperoxic Lung Injury in a Neonatal Rat Model
Merih Cetinkaya et al.
PLOS ONE (2015)
Modulation of angiotensin II signaling in the prevention of fibrosis
Amanda M. Murphy et al.
FIBROGENESIS & TISSUE REPAIR (2015)
Histone Deacetylase Inhibition Attenuates Cardiac Hypertrophy and Fibrosis through Acetylation of Mineralocorticoid Receptor in Spontaneously Hypertensive Rats
Seol-Hee Kang et al.
MOLECULAR PHARMACOLOGY (2015)
PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptors
Chunsheng Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38/ERK MAPK and apoptotic pathways: Study in juvenile diabetic rat
S. Khan et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2014)
Molecular mechanisms of diabetic cardiomyopathy
Heiko Bugger et al.
DIABETOLOGIA (2014)
Cardioprotective effects of magnesium valproate in type 2 diabetes mellitus
Bhoomika M. Patel et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Crosstalk between TGF-β1 and complement activation augments epithelial injury in pulmonary fibrosis
Hongmei Gu et al.
FASEB JOURNAL (2014)
Sodium butyrate, a HDAC inhibitor ameliorates eNOS, iNOS and TGF-β1-induced fibrogenesis, apoptosis and DNA damage in the kidney of juvenile diabetic rats
Sabbir Khan et al.
FOOD AND CHEMICAL TOXICOLOGY (2014)
Modulation of Treg function improves adenovirus vector-mediated gene expression in the airway
Y. Nagai et al.
GENE THERAPY (2014)
Interleukin-6 (IL-6) Trans Signaling Drives a STAT3-dependent Pathway That Leads to Hyperactive Transforming Growth Factor-β (TGF-β) Signaling Promoting SMAD3 Activation and Fibrosis via Gremlin Protein
Steven O'Reilly et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Targeting cardiac fibroblasts to treat fibrosis of the heart: Focus on HDACs
Katherine B. Schuetze et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Valproic Acid Prevents Penile Fibrosis and Erectile Dysfunction in Cavernous Nerve-Injured Rats
Johanna L. Hannan et al.
JOURNAL OF SEXUAL MEDICINE (2014)
HDAC4 blocks autophagy to trigger podocyte injury: non-epigenetic action in diabetic nephropathy
Qingqing Wei et al.
KIDNEY INTERNATIONAL (2014)
Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy
Xiaojie Wang et al.
KIDNEY INTERNATIONAL (2014)
TRPA1 is required for TGF-β signaling and its loss blocks inflammatory fibrosis in mouse corneal stroma
Yuka Okada et al.
LABORATORY INVESTIGATION (2014)
Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease
Helena M. Kok et al.
NATURE REVIEWS NEPHROLOGY (2014)
The Effect of Antifibrotic Drugs in Rat Precision-Cut Fibrotic Liver Slices
Inge M. Westra et al.
PLOS ONE (2014)
Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis
Silvia Svegliati et al.
SCIENCE SIGNALING (2014)
Autophagy: Emerging Therapeutic Target for Diabetic Nephropathy
Shinji Kume et al.
SEMINARS IN NEPHROLOGY (2014)
Regulation of Autophagy by TGF-β: Emerging Role in Kidney Fibrosis
Yan Ding et al.
SEMINARS IN NEPHROLOGY (2014)
The Role of Dietary Histone Deacetylases (HDACs) Inhibitors in Health and Disease
Shalome A. Bassett et al.
NUTRIENTS (2014)
Macrophages promote renal fibrosis through direct and indirect mechanisms
David J. Nikolic-Paterson et al.
KIDNEY INTERNATIONAL SUPPLEMENTS (2014)
HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation
Hikmet F. Nural-Guvener et al.
FIBROGENESIS & TISSUE REPAIR (2014)
Strategies for anti-fibrotic therapies
Joel Rosenbloom et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Epigenetic regulation of wound healing and fibrosis
Jelena Mann et al.
CURRENT OPINION IN RHEUMATOLOGY (2013)
Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure
Yu-Hsun Kao et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
HDAC Inhibition Suppresses Cardiac Hypertrophy and Fibrosis in DOCA-Salt Hypertensive Rats via Regulation of HDAC6/HDAC8 Enzyme Activity
Hae Jin Kee et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2013)
Small Molecule Inhibitors of Zinc-dependent Histone Deacetylases
Florence F. Wagner et al.
NEUROTHERAPEUTICS (2013)
Tumor budding, myofibroblast proliferation, and fibrosis in obstructing colon carcinoma: The roles of Hsp47 and basic fibroblast growth factor
Chuan-Jie Xu et al.
PATHOLOGY RESEARCH AND PRACTICE (2013)
Comparison of trichostatin A and valproic acid treatment regimens in a mouse model of kidney fibrosis
Katrien Van Beneden et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
HDAC inhibitors in experimental liver and kidney fibrosis
Katrien Van Beneden et al.
FIBROGENESIS & TISSUE REPAIR (2013)
The antifibrotic effect of a serine protease inhibitor in the kidney
Jun Morinaga et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Investigating drug repositioning opportunities in FDA drug labels through topic modeling
Halil Bisgin et al.
BMC BIOINFORMATICS (2012)
TGF-β in progression of liver disease
Steven Dooley et al.
CELL AND TISSUE RESEARCH (2012)
Impaired IL-17 Signaling Pathway Contributes to the Increased Collagen Expression in Scleroderma Fibroblasts
Taiji Nakashima et al.
JOURNAL OF IMMUNOLOGY (2012)
Cystic fibrosis: a mucosal immunodeficiency syndrome
Taylor Sitarik Cohen et al.
NATURE MEDICINE (2012)
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Thomas A. Wynn et al.
NATURE MEDICINE (2012)
PPARγ as a therapeutic target in cystic fibrosis
Johanna F. Dekkers et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors
Genevieve P. Delcuve et al.
CLINICAL EPIGENETICS (2012)
Wound-Associated Skin Fibrosis: Mechanisms and Treatments Based on Modulating the Inflammatory Response
Tanya J. Shaw et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2012)
Roles and Targets of Class I and IIa Histone Deacetylases in Cardiac Hypertrophy
Hae Jin Kee et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Histone Deacetylase 1/2 Mediates Proliferation of Renal Interstitial Fibroblasts and Expression of Cell Cycle Proteins
Maoyin Pang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Valproic Acid Attenuates Proteinuria and Kidney Injury
Katrien Van Beneden et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Autophagy Protects the Proximal Tubule from Degeneration and Acute Ischemic Injury
Tomonori Kimura et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Investigation on sodium valproate induced germ cell damage, oxidative stress and genotoxicity in male Swiss mice
Sabbir Khan et al.
REPRODUCTIVE TOXICOLOGY (2011)
Histone deacetylase inhibitors: A chemical genetics approach to understanding cellular functions
Paul A. Marks
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Sodium Valproate, a Histone Deacetylase Inhibitor, but Not Captopril, Prevents Right Ventricular Hypertrophy in Rats
Young Kuk Cho et al.
CIRCULATION JOURNAL (2010)
Chronic Administration of Valproic Acid Inhibits Activation of Mouse Hepatic Stellate Cells In Vitro and In Vivo
Inge Mannaerts et al.
HEPATOLOGY (2010)
Amelioration of Penile Fibrosis: Myth or Reality
Ahmed I. El-Sakka et al.
JOURNAL OF ANDROLOGY (2010)
Epigenetically Altered Wound Healing in Keloid Fibroblasts
Shirley B. Russell et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Histone Deacetylase: A Potential Therapeutic Target for Fibrotic Disorders
Maoyin Pang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Valproate and Bone Loss: iTRAQ Proteomics Show that Valproate Reduces Collagens and Osteonectin in SMA Cells
Heidi R. Fuller et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Strategies in Developing Promising Histone Deacetylase Inhibitors
Lei Zhang et al.
MEDICINAL RESEARCH REVIEWS (2010)
Epigenetics: molecular mechanisms and implications for disease
Adam E. Handel et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury
Takeshi Marumo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Histone Deacetylase 7, a Potential Target for the Antifibrotic Treatment of Systemic Sclerosis
Hossein Hemmatazad et al.
ARTHRITIS AND RHEUMATISM (2009)
Histone modifying enzymes: Structures, mechanisms, and specificities
Ronen Marmorstein et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2009)
An operational definition of epigenetics
Shelley L. Berger et al.
GENES & DEVELOPMENT (2009)
Differential regulation of connective tissue growth factor in renal cells by histone deacetylase inhibitors
Claudiu Komorowsky et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Mechanisms of Penile Fibrosis
Nestor F. Gonzalez-Cadavid
JOURNAL OF SEXUAL MEDICINE (2009)
Histone Deacetylase Inhibitors Target Diabetes via Chromatin Remodeling or as Chemical Chaperones?
M. W. Lawless et al.
CURRENT DIABETES REVIEWS (2009)
Cellular and molecular mechanisms of fibrosis
T. A. Wynn
JOURNAL OF PATHOLOGY (2008)
The epigenetic signature of CFTR expression is co-ordinated via chromatin acetylation through a complex intronic element
Thankam Paul et al.
BIOCHEMICAL JOURNAL (2007)
Valproic acid (VPA) in patients with refractory advanced cancer:: a dose escalating phase I clinical trial
A. Atmaca et al.
BRITISH JOURNAL OF CANCER (2007)
Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies
Stefanie Hemmann et al.
JOURNAL OF HEPATOLOGY (2007)
Matrix metalloproteinases (MMPs): Chemical-biological functions and (Q)SARs
Rajeshwar P. Verma et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Paramutation: From maize to mice
Vicki L. Chandler
CELL (2007)
Epigenetics: A landscape takes shape
Aaron D. Goldberg et al.
CELL (2007)
Regulation of cardiac hypertrophy by intracellular signalling pathways
Joerg Heineke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Activation of TGF-β1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats
M Matsumoto-Ida et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Control of cardiac growth by histone acetylation/deacetylation
J Backs et al.
CIRCULATION RESEARCH (2006)
Oxidative stress as a mechanism of valproic acid-associated hepatotoxicity
Thomas K. H. Chang et al.
DRUG METABOLISM REVIEWS (2006)
Antifibrotic activity of an inhibitor of group IIA secretory phospholipase A(2) in young spontaneously hypertensive rats
Scott Levick et al.
JOURNAL OF IMMUNOLOGY (2006)
Histone deacetylase inhibitors and cancer: from cell biology to the clinic
H Hess-Stumpp
EUROPEAN JOURNAL OF CELL BIOLOGY (2005)
Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth
B Sanna et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Activation of CDK4 gene expression in human breast cancer cells by the Brn-3b POU family transcription factor
L Samady et al.
CANCER BIOLOGY & THERAPY (2004)
Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation
M Nissim-Rafinia et al.
EMBO REPORTS (2004)
Epigenetics in human disease and prospects for epigenetic therapy
G Egger et al.
NATURE (2004)
Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors
CL Antos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Liver fibrosis - from bench to bedside
SL Friedman
JOURNAL OF HEPATOLOGY (2003)
Gene expression in fibroblasts and fibrosis - Involvement in cardiac hypertrophy
I Manabe et al.
CIRCULATION RESEARCH (2002)
Interleukin-1β induces human proximal tubule cell injury, α-smooth muscle actin expression and fibronectin production
DA Vesey et al.
KIDNEY INTERNATIONAL (2002)
Extracellular matrix degradation and the role of hepatic stellate cells
RC Benyon et al.
SEMINARS IN LIVER DISEASE (2001)
The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
OF Bueno et al.
EMBO JOURNAL (2000)
Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury
SL Friedman
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
